Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 4;24(1):549.
doi: 10.1186/s13054-020-03267-w.

COVID-19: more than a cytokine storm

Giovanni Riva  1 , Vincenzo Nasillo  2 , Enrico Tagliafico  1 , Tommaso Trenti  1 , Patrizia Comoli  3 , Mario Luppi  4
Affiliations

COVID-19: more than a cytokine storm

Giovanni Riva et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declared that they have no conflicts of interest to this work.

Figures

Fig. 1
Fig. 1
Working model for COVID-19 immunopathogenesis and related immunomodulatory treatments. Acronyms: SARS-CoV-2 severe acute respiratory syndrome-coronavirus-2, SARS severe acute respiratory syndrome, SIRS severe inflammatory response syndrome, sHLH secondary hemophagocytic lymphohistiocytosis, MAS macrophage activation syndrome, CRS cytokine release syndrome, KICS Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome, COVID-19 coronavirus disease-19, DIC disseminated intravascular coagulation
See this image and copyright information in PMC

References

    1. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S0140-6736(20)30628-0. - DOI - PMC - PubMed
    1. McGonagle D, Sharif K, O'Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi: 10.1016/j.autrev.2020.102537. - DOI - PMC - PubMed
    1. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi: 10.1126/science.abb8925. - DOI - PubMed
    1. Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi: 10.1172/JCI137244. - DOI - PMC - PubMed
    1. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi: 10.1093/cid/ciaa248. - DOI - PMC - PubMed

LinkOut - more resources